Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Comparison between touchscreen operant chambers and water maze to detect early prefrontal dysfunction in mice

Van den Broeck L, Sierksma A, Hansquine P, Thonnard D, Callaerts-Vegh Z, D'Hooge R.

Genes Brain Behav. 2021 Jan;20(1):e12695. doi: 10.1111/gbb.12695. Epub 2020 Oct 4.

Dendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer's Disease

Walker CK, Herskowitz JH.

Neuroscientist. 2021 Oct;27(5):487-505. doi: 10.1177/1073858420945964. Epub 2020 Aug 19.

Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease

Uddin MS, Kabir MT, Begum MM, Islam MS, Behl T, Ashraf GM.

Neurotox Res. 2021 Dec;39(6):2108-2119. doi: 10.1007/s12640-020-00271-4. Epub 2020 Aug 21.

Shared signaling pathways in Alzheimer's and metabolic disease may point to new treatment approaches

Suresh J, Khor IW, Kaur P, Heng HL, Torta F, Dawe GS, Tai ES, Tolwinski NS.

FEBS J. 2021 Jun;288(12):3855-3873. doi: 10.1111/febs.15540. Epub 2020 Sep 10.

Mentorship and Training to Increase Diversity of Researchers and Practitioners in the Field of Aging and Alzheimer's Disease: A Scoping Review of Program Characteristics

Ureña S, Ingram LA, Leith K, Lohman MC, Resciniti N, Rubin L, Miller MC, Friedman DB.

J Aging Health. 2021 Jan;33(1-2):48-62. doi: 10.1177/0898264320953345. Epub 2020 Aug 31.

Novel Targets for Alzheimer's Disease: A View Beyond Amyloid

Ray WJ, Buggia-Prevot V.

Annu Rev Med. 2021 Jan 27;72:15-28. doi: 10.1146/annurev-med-052919-120219. Epub 2020 Aug 31.

Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery

Zameer S, Ali J, Vohora D, Najmi AK, Akhtar M.

J Drug Target. 2021 Feb;29(2):199-216. doi: 10.1080/1061186X.2020.1817041. Epub 2020 Sep 10.

Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's disease

Kent BA, Feldman HH, Nygaard HB.

Prog Neurobiol. 2021 Feb;197:101902. doi: 10.1016/j.pneurobio.2020.101902. Epub 2020 Aug 30.

High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease

Pedrini S, Chatterjee P, Hone E, Martins RN.

J Neurochem. 2021 Oct;159(2):343-377. doi: 10.1111/jnc.15170. Epub 2020 Oct 27.

Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease

Kabir MT, Uddin MS, Zaman S, Begum Y, Ashraf GM, Bin-Jumah MN, Bungau SG, Mousa SA, Abdel-Daim MM.

Mol Neurobiol. 2021 Jan;58(1):1-20. doi: 10.1007/s12035-020-02096-w. Epub 2020 Sep 5.

The Sleep Side of Aging and Alzheimer's Disease

Romanella SM, Roe D, Tatti E, Cappon D, Paciorek R, Testani E, Rossi A, Rossi S, Santarnecchi E.

Sleep Med. 2021 Jan;77:209-225. doi: 10.1016/j.sleep.2020.05.029. Epub 2020 May 30.

Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets

Uddin MS, Al Mamun A, Kabir MT, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM.

Mol Neurobiol. 2021 Jan;58(1):281-303. doi: 10.1007/s12035-020-02116-9. Epub 2020 Sep 15.

A Systematic Review of Altered P300 Event-Related Potential in Apolipoprotein E4 (APOE4) Carriers

Pedroso RV, Fraga FJ, Pavarini SCI, Nascimento CMC, Ayán C, Cominetti MR.

Clin EEG Neurosci. 2021 May;52(3):193-200. doi: 10.1177/1550059420959966. Epub 2020 Sep 18.

Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease

Goyal D, Ali SA, Singh RK.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16.

d-serine in physiological and pathological brain aging

Ploux E, Freret T, Billard JM.

Biochim Biophys Acta Proteins Proteom. 2021 Jan;1869(1):140542. doi: 10.1016/j.bbapap.2020.140542. Epub 2020 Sep 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias